Opinion

Video

Clinical Efficacy of Non-Statin Treatment Options in ASCVD

Author(s):

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP,Kate Cabral, PharmD, BCCP, FACC, FCCP

Focusing on PCSK9 inhibitors, inclisiran, and bempedoic acid, the panel compares treatment efficacy and outlines patient factors that influence treatment decisions.

Related Videos
Hands holding a crochet heart | Image Credit: © StockerThings - stock.adobe.com
Wooden blocks spelling HDL, LDL | Image Credit: © surasak - stock.adobe.com
Anticoagulant attacking blood clot | Image Credit: © BURIN93 - stock.adobe.com
Depiction of man aging | Image Credit: © Top AI images - stock.adobe.com
Map with pins | Image Credit: © Tryfonov - stock.adobe.com
Heart with stethoscope | Image Credit: © DARIKA - stock.adobe.com
Image Credit: © abricotine - stock.adobe.com
This series features 5 KOLs.
This series features 5 KOLs.
This series features 5 KOLs.
Related Content
Blood cells | Image Credit: © Formoney - stock.adobe.com
November 19th 2024

Abelacimab Reduces Bleeding in AF Patients on Antiplatelet Therapy

Alexandra Gerlach, Associate Editor
AHA 2024: Email Reminders Improve Flu Shot Rates, Particularly Among Heart Attack Survivors
November 18th 2024

AHA 2024: Email Reminders Improve Flu Shot Rates, Particularly Among Heart Attack Survivors

Aislinn Antrim, MA, Assistant Managing Editor
AHA 2024: Integrating Ambulatory Care Pharmacists in Value-Based Primary Care Improves Cardiometabolic Disease Management
November 17th 2024

AHA 2024: Integrating Ambulatory Care Pharmacists in Value-Based Primary Care Improves Cardiometabolic Disease Management

Aislinn Antrim, MA, Assistant Managing Editor
AHA 2024: Providing Feedback for Pharmacists Improved Care for Veterans With Heart Failure
November 16th 2024

AHA 2024: Providing Feedback for Pharmacists Improved Care for Veterans With Heart Failure

Aislinn Antrim, MA, Assistant Managing Editor
AHA 2024: Tirzepatide Lowers Risk of Worsening Heart Failure, CVD Death in Adults With Obesity
Published: November 16th 2024 | Updated: November 16th 2024

AHA 2024: Tirzepatide Lowers Risk of Worsening Heart Failure, CVD Death in Adults With Obesity

Aislinn Antrim, MA, Assistant Managing Editor
AHA 2024: AI Tool Could Provide Fast, No-Contact Blood Pressure and Diabetes Screenings
November 15th 2024

AHA 2024: AI Tool Could Provide Fast, No-Contact Blood Pressure and Diabetes Screenings

Aislinn Antrim, MA, Assistant Managing Editor